还原型谷胱甘肽

Records for this ingredient, by country (identity only).

ATC A05BA · 1 markets · 20 records

还原型谷胱甘肽 1 markets · 20 records Forms
Filters
MarketCN 20

CN 20 records · 6 shown of 6 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 600 mg per mL / per unit basis not statedinjection泰特还原型谷胱甘肽Manufacturer: 瑞阳制药股份有限公司、Manufacturer: 福安药业集团湖北人民制药有限公司
  • 1,200 mg per mL / per unit basis not statedinjectionManufacturer: 瑞阳制药股份有限公司 ×4Manufacturer: 福安药业集团湖北人民制药有限公司
  • 100 mg/5 mLliquid天亿还原型谷胱甘肽
  • 1,500 mg per mL / per unit basis not statedinjectionManufacturer: 福安药业集团湖北人民制药有限公司 ×13
  • 1,000 mg per mL / per unit basis not statedinjectionManufacturer: 福安药业集团湖北人民制药有限公司 ×13
  • 900 mg per mL / per unit basis not statedinjectionManufacturer: 福安药业集团湖北人民制药有限公司 ×13

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.